| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $108.0M | -8.3% |
| Cost of Revenue | $27.1M | +2.5% |
| Gross Profit | $81.0M | -11.5% |
| R&D Expense | $800K | +14.3% |
| SG&A Expense | $39.7M | -4.9% |
| Operating Income | -$426K | -129.8% |
| Pre-tax Income | -$2.9M | -177.2% |
| Income Tax | $12.3M | +885.9% |
| Net Income | -$15.2M | -711.0% |
| EPS (Basic) | -$8.00 | -706.1% |
| EPS (Diluted) | -$8.00 | -706.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.2M | -45.7% |
| Accounts Receivable | $1K | -94.7% |
| Inventory | $10.1M | -2.7% |
| Current Assets | $20.6M | -21.2% |
| Total Assets | $30.0M | -16.8% |
| Current Liabilities | $18.7M | -10.3% |
| Long-term Debt | $2.8M | — |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -231.0% |
| Capital Expenditures | $1.4M | +355.6% |
| Investing Cash Flow | -$1.4M | -374.7% |
| Financing Cash Flow | -$561K | -128.6% |
| Free Cash Flow | -$4.3M | -319.8% |
| $35.2M |
| +28.3% |
| Stockholders' Equity | -$5.2M | -160.6% |